Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease

Neurology. 1998 Apr;50(4):1195-6. doi: 10.1212/wnl.50.4.1195-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines
  • Dopamine Agonists / adverse effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Olanzapine
  • Parkinson Disease / drug therapy*
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / therapeutic use
  • Psychoses, Substance-Induced / drug therapy*

Substances

  • Antipsychotic Agents
  • Dopamine Agonists
  • Benzodiazepines
  • Pirenzepine
  • Olanzapine